NRC Health/$NRC

1D1W1MYTD1Y5YMAX

About NRC Health

NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
Ticker
$NRC
Sector
Health
Primary listing
NASDAQ
Employees
357

NRC Health Metrics

BasicAdvanced
$470M
88.48
$0.24
0.37
$0.60
3.01%

What the Analysts think about NRC Health

Analyst ratings (Buy, Hold, Sell) for NRC Health stock.
Analyst projections of the future price of NRC Health stock.

Bulls say / Bears say

Total Recurring Contract Value rose 11% year on year to $151.9 million in the second quarter, after growing 13% in the first quarter. NRC also says it signed the largest deal in its history, giving future revenue a stronger base as the customer rolls out. (NRC Health, Business Wire)
NRC is adding healthcare-specific ambient listening and agentic AI to its rounding product, with early pilots reporting much richer documentation. A 91.6 KLAS performance score for NRC Health Rounding and a major customer expansion support the case that the product is gaining market credibility. (NRC Health, NRC Health)
The underlying business is still generating cash while NRC invests for growth: first-half free cash flow was $5.4 million and second-quarter adjusted EBITDA was $9.4 million, or 27% of revenue. That gives the company some capacity to fund product development and maintain its $0.16 quarterly dividend. (NRC Health, Last10K)
Reported profitability weakened sharply despite higher revenue. NRC posted a $3.3 million second-quarter net loss, while first-half net income fell to a small loss from a $5.7 million profit a year earlier as selling, general and administrative costs rose materially. (NRC Health, Last10K)
The balance sheet leaves little room for execution mistakes: at 30 June, NRC had only $3.3 million of cash against about $90 million of borrowings, while shareholders’ equity had fallen to $6.5 million. Dividends and share repurchases could compete with debt reduction if cash generation disappoints. (Last10K, NRC Health)
The strong contract-value growth is not yet converting into reported revenue at the same pace: second-quarter TRCV rose 11%, but revenue increased only 4%. Management also said the sales pipeline’s average deal size had fallen, so implementation timing and smaller new contracts could limit near-term growth. (NRC Health, Exa)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.

NRC Health Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

NRC Health Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing NRC Health

Funds
Fund name
Fund size
$NRC weighting
SPDR Russell 2000 US Small Cap€R2US
€4.8B0.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.